Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan

Structure-response and binding analysis with analogs of levosimendan

J. Levijoki, P. Pollesello, J. Kaivola, C. Tilgmann, T. Sorsa, Arto Annila, Ilkka Kilpeläinen, H. Haikala (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

67 Citations (Scopus)

Abstract

Levosimendan, an inodilatory drug discovered using troponin C as a target protein, has a cardiac effect deriving from the calcium sensitization of contractile proteins. The aim of this study was to give further evidence that levosimendan binds to cardiac troponin C and that the binding involves amino acid residues on helixϵ of the N-terminal domain of this calcium-binding protein. Nine organic molecules, obtained by chemical modification of levosimendan, were tested both for their calcium-dependent binding to troponin C and troponin complex affinity HPLC columns, and for their ability to increase the calcium sensitivity of myofilaments in cardiac skinned fibers. A good correlation between the calcium sensitization and the calcium-dependent binding to troponin complex (r=0.90) and to cardiac troponin C (r=0.91) for the analogs of levosimendan was shown. In addition, the effect of levosimendan on the calcium-induced conformational changes in native and point-mutated cTnC was studied. Cys84→Ser, Asp87→Lys and Asp88→Ala point-mutated cTnC were shown to maintain a high affinity to calcium, but their Ca2+titration curves were not influenced by levosimendan as for the native protein. Finally, it was demonstrated that the NMR chemical shifts of the terminal methyl groups of Met47, Met81, and Met85 on calcium-saturated cTnC were changed after addition of levosimendan in water solution at pH 7.4. This effect was not seen when adding an analog of levosimendan, which did not bind to the troponin C affinity HPLC column and did not increase the calcium-induced tension in cardiac skinned fibers.

Original languageEnglish
Pages (from-to)479 - 491
Number of pages13
JournalJournal of Molecular and Cellular Cardiology
Volume32
Issue number3
DOIs
Publication statusPublished - 2000
MoE publication typeA1 Journal article-refereed

Fingerprint

Troponin C
Calcium
Troponin
High Pressure Liquid Chromatography
simendan
Contractile Proteins
Calcium-Binding Proteins
Myofibrils
Proteins
Amino Acids

Cite this

Levijoki, J. ; Pollesello, P. ; Kaivola, J. ; Tilgmann, C. ; Sorsa, T. ; Annila, Arto ; Kilpeläinen, Ilkka ; Haikala, H. / Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan : Structure-response and binding analysis with analogs of levosimendan. In: Journal of Molecular and Cellular Cardiology. 2000 ; Vol. 32, No. 3. pp. 479 - 491.
@article{332f20597fa74b3faa23c657d98a674c,
title = "Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: Structure-response and binding analysis with analogs of levosimendan",
abstract = "Levosimendan, an inodilatory drug discovered using troponin C as a target protein, has a cardiac effect deriving from the calcium sensitization of contractile proteins. The aim of this study was to give further evidence that levosimendan binds to cardiac troponin C and that the binding involves amino acid residues on helixϵ of the N-terminal domain of this calcium-binding protein. Nine organic molecules, obtained by chemical modification of levosimendan, were tested both for their calcium-dependent binding to troponin C and troponin complex affinity HPLC columns, and for their ability to increase the calcium sensitivity of myofilaments in cardiac skinned fibers. A good correlation between the calcium sensitization and the calcium-dependent binding to troponin complex (r=0.90) and to cardiac troponin C (r=0.91) for the analogs of levosimendan was shown. In addition, the effect of levosimendan on the calcium-induced conformational changes in native and point-mutated cTnC was studied. Cys84→Ser, Asp87→Lys and Asp88→Ala point-mutated cTnC were shown to maintain a high affinity to calcium, but their Ca2+titration curves were not influenced by levosimendan as for the native protein. Finally, it was demonstrated that the NMR chemical shifts of the terminal methyl groups of Met47, Met81, and Met85 on calcium-saturated cTnC were changed after addition of levosimendan in water solution at pH 7.4. This effect was not seen when adding an analog of levosimendan, which did not bind to the troponin C affinity HPLC column and did not increase the calcium-induced tension in cardiac skinned fibers.",
author = "J. Levijoki and P. Pollesello and J. Kaivola and C. Tilgmann and T. Sorsa and Arto Annila and Ilkka Kilpel{\"a}inen and H. Haikala",
year = "2000",
doi = "10.1006/jmcc.1999.1093",
language = "English",
volume = "32",
pages = "479 -- 491",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press",
number = "3",

}

Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan : Structure-response and binding analysis with analogs of levosimendan. / Levijoki, J.; Pollesello, P.; Kaivola, J.; Tilgmann, C.; Sorsa, T.; Annila, Arto; Kilpeläinen, Ilkka; Haikala, H. (Corresponding Author).

In: Journal of Molecular and Cellular Cardiology, Vol. 32, No. 3, 2000, p. 479 - 491.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan

T2 - Structure-response and binding analysis with analogs of levosimendan

AU - Levijoki, J.

AU - Pollesello, P.

AU - Kaivola, J.

AU - Tilgmann, C.

AU - Sorsa, T.

AU - Annila, Arto

AU - Kilpeläinen, Ilkka

AU - Haikala, H.

PY - 2000

Y1 - 2000

N2 - Levosimendan, an inodilatory drug discovered using troponin C as a target protein, has a cardiac effect deriving from the calcium sensitization of contractile proteins. The aim of this study was to give further evidence that levosimendan binds to cardiac troponin C and that the binding involves amino acid residues on helixϵ of the N-terminal domain of this calcium-binding protein. Nine organic molecules, obtained by chemical modification of levosimendan, were tested both for their calcium-dependent binding to troponin C and troponin complex affinity HPLC columns, and for their ability to increase the calcium sensitivity of myofilaments in cardiac skinned fibers. A good correlation between the calcium sensitization and the calcium-dependent binding to troponin complex (r=0.90) and to cardiac troponin C (r=0.91) for the analogs of levosimendan was shown. In addition, the effect of levosimendan on the calcium-induced conformational changes in native and point-mutated cTnC was studied. Cys84→Ser, Asp87→Lys and Asp88→Ala point-mutated cTnC were shown to maintain a high affinity to calcium, but their Ca2+titration curves were not influenced by levosimendan as for the native protein. Finally, it was demonstrated that the NMR chemical shifts of the terminal methyl groups of Met47, Met81, and Met85 on calcium-saturated cTnC were changed after addition of levosimendan in water solution at pH 7.4. This effect was not seen when adding an analog of levosimendan, which did not bind to the troponin C affinity HPLC column and did not increase the calcium-induced tension in cardiac skinned fibers.

AB - Levosimendan, an inodilatory drug discovered using troponin C as a target protein, has a cardiac effect deriving from the calcium sensitization of contractile proteins. The aim of this study was to give further evidence that levosimendan binds to cardiac troponin C and that the binding involves amino acid residues on helixϵ of the N-terminal domain of this calcium-binding protein. Nine organic molecules, obtained by chemical modification of levosimendan, were tested both for their calcium-dependent binding to troponin C and troponin complex affinity HPLC columns, and for their ability to increase the calcium sensitivity of myofilaments in cardiac skinned fibers. A good correlation between the calcium sensitization and the calcium-dependent binding to troponin complex (r=0.90) and to cardiac troponin C (r=0.91) for the analogs of levosimendan was shown. In addition, the effect of levosimendan on the calcium-induced conformational changes in native and point-mutated cTnC was studied. Cys84→Ser, Asp87→Lys and Asp88→Ala point-mutated cTnC were shown to maintain a high affinity to calcium, but their Ca2+titration curves were not influenced by levosimendan as for the native protein. Finally, it was demonstrated that the NMR chemical shifts of the terminal methyl groups of Met47, Met81, and Met85 on calcium-saturated cTnC were changed after addition of levosimendan in water solution at pH 7.4. This effect was not seen when adding an analog of levosimendan, which did not bind to the troponin C affinity HPLC column and did not increase the calcium-induced tension in cardiac skinned fibers.

U2 - 10.1006/jmcc.1999.1093

DO - 10.1006/jmcc.1999.1093

M3 - Article

VL - 32

SP - 479

EP - 491

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 3

ER -